How Celltrion's New Supply Contracts for Omlyclo and Avtozma Are Revolutionizing U.S. Healthcare
AI 요약 정보
- Celltrion signs exclusive U.S. supply deals for Omlyclo, Avtozma
- Both drugs gain preferred status on insurer formulary
- Omlyclo joins a discount program serving about 74 million
